Skip to main content
. 2014 Dec 23;12(2):393–402. doi: 10.1021/mp5003569

Table 3. Pharmacokinetic Properties of VMY-2-95 in Plasma after Oral Administration to SD Ratsa.

parameter VMY-2-95·2HCl
Cmax (μg/mL) 0.56 ± 0.02
Tmax (h) 0.92 ± 0.59
T1/2 (h) 8.98 ± 2.36
AUC0-last (μg/mL·h) 7.05 ± 1.61
MRT (h) 8.03 ± 2.36
a

AUC, area under the curve; MRT, mean residence time.